FDA OKs Switching From Stable HIV Regimen to Complera

The U.S. Food and Drug Administration has approved Gilead Sciences' coformulated triple antiretroviral combination tablet Complera for those HIV-positive adults who switch from a stable ARV regimen.

http://www.poz.com/rssredir/articles/Compera_switch_761_24947.shtml